17 unchanged sentences
2018 Equity Incentive Plan
−Removed: Stock Option Award Agreement under 2018 Equity Incentive Plan
−Removed: Notice of Stock Option Grant under 2018 Equity Incentive Plan
−Removed: Restricted Stock Unit Award Agreement under 2018 Equity Incentive Plan
−Removed: Notice of Restricted Stock Unit Award under 2018 Equity Incentive Plan
+Added: 2024 Equity Incentive Plan
Revolving Line of Credit Agreement dated June 30, 2020, between Clyra Medical and Vernal Bay
2 unchanged sentences
Warrant issued in BioLargo Unit Offerings (through January 16, 2024)
−Removed: Amendment to March 2018 $50,000 Convertible Note, dated March 8, 2018
−Removed: Warrant issued to $50,000 Convertible Noteholder on March 1, 2020
−Removed: Satisfaction of March 2018 Convertible Note, dated March 6, 2023
BioLargo license to Clyra Medical Technologies, Inc., dated March 1, 2024
39 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: November 14, 2024
BIOLARGO, INC.
1 unchanged sentence
Chief Executive Officer
−Removed: November 14, 2024
/s/ CHARLES K.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.